The collaboration between CORONA and Ferring will cater to patients across India
Results showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival
The two generic drugs have been launched under the brand names Jankey & Sitenali.
The FDA informed Astellas that it did not have sufficient information to assess the risks to subjects
Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
Phase 2a clinical proof-of-concept biomarker study for PXL065 in ALD now anticipated to start midyear
Studies show significant reduction in pain and improved quality of life for patients treated with spinal cord stimulation compared to medication management alone
The FDA grants ODD status to medicines and potential new medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the US
This advanced technology for Diabetic Foot Ulcer (DFU), management has a high scope of preventing amputations in diabetic patients. It has no definitive treatment in India. This technology will be available at affordable rates
Healtherbs helps in restoring the desired energy levels for daily activity and immunity
Subscribe To Our Newsletter & Stay Updated
